Chikungunya is a mosquito-borne viral disease caused by the Chikungunya virus (CHIKV), an RNA virus of the Alphavirus genus and Togaviridae family. Transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, the disease typically manifests within 2 to 12 days of infection, with sudden onset of high fever, severe joint pain, swelling, headache, muscle aches, rashes, and fatigue. Unlike mild febrile illnesses, the hallmark symptom of intense joint pain may persist for weeks, months, or even years, severely affecting quality of life. Given its clinical similarity to Dengue and Zika, accurate and timely diagnosis is critical for effective patient management and outbreak control.
The Chikungunya-Q Real-Time PCR Kit from Genes2Me is a highly sensitive and specific in vitro diagnostic assay for the qualitative detection of CHIKV RNA in blood, serum, and plasma samples. By combining precise molecular targeting with robust quality controls, the kit accelerates diagnosis and supports better patient care and public health response.
Genes2Me is a CE Marked molecular diagnostics company trusted by clinical laboratories across global markets. The Chikungunya-Q Real-Time PCR Kit meets European conformity standards for in vitro diagnostic devices, validated to international benchmarks for accuracy, reliability, and safety.
The Chikungunya-Q kit is built on real-time RT-PCR technology with primers and probes specifically targeting the Polyprotein gene of CHIKV. Texas Red-labeled probes provide precise pathogen detection, while a built-in Internal Control in the HEX channel validates sample quality and PCR efficiency across every run. Positive and negative controls are included to ensure workflow reliability and eliminate false positive or negative results. Ready-to-use reagents and a straightforward protocol minimise hands-on time and reduce the potential for procedural errors.
Chikungunya fever presents with clinical features that closely overlap with Dengue and Zika, making symptom-based diagnosis unreliable. Serological assays may lack sensitivity during the early acute phase, when viral loads are at their highest and results are most actionable. Molecular detection of CHIKV RNA provides the earliest confirmation of active infection, ahead of antibody seroconversion, enabling prompt and appropriate clinical management. The assay has been tested for cross-reactivity against related arboviruses including Dengue, Zika, West Nile, and Yellow Fever, with no false positives observed, ensuring that results are specific to Chikungunya infection.
Analytical sensitivity of 100% and clinical specificity of 98%, with a Ct cut-off of 35 or below, ensuring accurate detection even at low viral loads.
The HEX-channel internal control validates sample quality and PCR efficiency in every run, safeguarding against false negatives arising from poor sample quality or PCR inhibition.
Ensure workflow reliability and eliminate false positive or negative results, confirming assay integrity in every run.
No false positives observed with related arboviruses including Dengue, Zika, West Nile, and Yellow Fever, confirming high assay specificity in clinically relevant differential diagnosis scenarios.
Precision testing demonstrating a coefficient of variation below 3% ensures consistent and reproducible performance across runs and operators.
Validated on RapiCycler 96, Bio-Rad CFX96, QuantStudio 5, and LightCycler 480, supporting seamless integration into existing laboratory workflows.
| Commercial Name | Old Cat No. | New Cat No. | Pack Size |
|---|---|---|---|
| Chikungunya-Q Real-Time PCR Kit | G2M705321 | 50 Tests |
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
